Metastatic Colorectal Cancer: Advances in Non-Chemotherapy Treatment Options

home / investigator-perspectives / metastatic-colorectal-cancer-advances-in-non-chemotherapy-treatment-options

John Marshall, MD, discusses the realities of metastatic colorectal cancer management and therapy options to consider outside of chemotherapy—regorafenib, in particular.

EP. 1: Getting to Know Colorectal Cancer

September 13th 2021

John Marshall, MD, provides an overview of the colorectal cancer landscape.

Watch

EP. 2: Frontline Treatment and Maintenance for Metastatic Colorectal Cancer

September 13th 2021

Dr Marshall explains the different frontline treatment options for metastatic colorectal cancer, as well as maintenance therapy.

Watch

EP. 3: Progression on Metastatic Colorectal Cancer Treatment

September 13th 2021

A gastrointestinal cancers expert describes monitoring strategies for progression of metastatic colorectal cancer.

Watch

EP. 4: Regorafenib as a Metastatic Colorectal Cancer Therapy Option

September 13th 2021

Dr Marshall discusses the impact regorafenib has had in the treatment of metastatic colorectal cancer and describes data from the CORRECT and ReDOS clinical trials.

Watch

EP. 5: Regorafenib Sequencing and the Future of Metastatic Colorectal Cancer Management

September 13th 2021

John Marshall, MD, speaks on regorafenib sequencing and relays his thoughts on the future of treatment for metastatic colorectal cancer.

Watch